Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 9:13:847499.
doi: 10.3389/fphar.2022.847499. eCollection 2022.

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations

Tahani M Almeleebia  1 , Shahzaib Ahamad  2 , Irfan Ahmad  3 , Ahmad Alshehri  4 , Ali G Alkhathami  3 , Mohammad Y Alshahrani  3 , Mohammed A Asiri  3 , Amir Saeed  5   6 , Jamshaid Ahmad Siddiqui  7 , Dharmendra K Yadav  8 , Mohd Saeed  9
Affiliations

Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations

Tahani M Almeleebia et al. Front Pharmacol. .

Abstract

Poly [adenosine diphosphate (ADP)-ribose] polymerases (PARPs) are members of a family of 17 enzymes that performs several fundamental cellular processes. Aberrant activity (mutation) in PARP12 has been linked to various diseases including inflammation, cardiovascular disease, and cancer. Herein, a large library of compounds (ZINC-FDA database) has been screened virtually to identify potential PARP12 inhibitor(s). The best compounds were selected on the basis of binding affinity scores and poses. Molecular dynamics (MD) simulation and binding free energy calculation (MMGBSA) were carried out to delineate the stability and dynamics of the resulting complexes. To this end, root means deviations, relative fluctuation, atomic gyration, compactness, covariance, residue-residue contact map, and free energy landscapes were studied. These studies have revealed that compounds ZINC03830332, ZINC03830554, and ZINC03831186 are promising agents against mutated PARP12.

Keywords: MD simulations; MMGBSA; PARP12; ZINC-FDA; virtual screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Optimized protocol employed in this work.
FIGURE 2
FIGURE 2
(A) Close-up view of the binding pockets (A* and B* encircled by black dotted lines) of the PARP12 enzyme. H-bond interactions between (B) ZINC03830332 (white stick), (C) ZINC03831186 (yellow stick), and PARP12 receptor (in green and blue color cartoon models). (D,E) 2D plot of the complexes.
FIGURE 3
FIGURE 3
(A) Mutation induced by PARP12 structures, (B) comparison of the RMSD plot, and (C) dynamic motion of projection in the eigenvector 1 vs. 2 and the plot two generated for the MD complexes showing conformational space of Cα-atoms.
FIGURE 4
FIGURE 4
Root mean square fluctuations (RMSFs) of mutant systems of PARP12 and (A) ZINC03830332, (B) ZINC03830554, (C) ZINC03831186, and (D) ZINC03831189.
FIGURE 5
FIGURE 5
(A) Rg and (B) SASA fluctuations per residue variation plot analysis of the mutant system and in the presence of compounds with PARP12 at total simulation time.
FIGURE 6
FIGURE 6
FEL direction of motion and magnitude analysis of the mutant PARP12 (A) and complexes with ZINC03830332 (B), ZINC03830554 (C), ZINC03831186, and (D) ZINC03831189 (E) throughout MD simulations. The color bar denotes the relative free energy value between 0 and 19.1 kcal mol−1.
See this image and copyright information in PMC

References

    1. Abraham M. J., Murtola T., Schulz R., Páll S., Smith J. C., Hess B., et al. (2015). GROMACS: High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers. SoftwareX 1-2, 19–25. 10.1016/j.softx.2015.06.001 - DOI
    1. Ahamad S., Hema K., Kumar V., Gupta D. (2021a). The Structural, Functional, and Dynamic Effect of Tau Tubulin Kinase1 upon a Mutation: A Neuro-Degenerative Hotspot. J. Cell Biochem. 122, 1653–1664. 10.1002/jcb.30112 - DOI - PubMed
    1. Ahamad S., Islam A., Ahmad F., Dwivedi N., Hassan M. I. (2019). 2/3D-QSAR, Molecular Docking and MD Simulation Studies of FtsZ Protein Targeting Benzimidazoles Derivatives. Comput. Biol. Chem. 78, 398–413. 10.1016/j.compbiolchem.2018.12.017 - DOI - PubMed
    1. Ahamad S., Kanipakam H., Kumar V., Gupta D. (2021b). A Molecular Journey to Check the Conformational Dynamics of Tau Tubulin Kinase 2 Mutations Associated with Alzheimer's Disease. RSC Adv. 11, 1320–1331. 10.1039/d0ra07659g - DOI - PMC - PubMed
    1. Ali S., Khan F. I., Mohammad T., Lan D., Hassan M. I., Wang Y. (2019). Identification and Evaluation of Inhibitors of Lipase from Malassezia Restricta Using Virtual High-Throughput Screening and Molecular Dynamics Studies. Int. J. Mol. Sci. 20, 884. 10.3390/ijms20040884 - DOI - PMC - PubMed

LinkOut - more resources